MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 1c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Capitol Federal Financial names William Skrobacz Jr. as president
• Teamshares raises $225M in preferred equity from T. Rowe Price